Genetic analysis of H-ras intron-1 polymorphic and variable tandem repeat regions in human breast cancer

International Journal of Biological Markers

Volumn 18, Issue 3, 2003, Pages 195-199

  Papadakis, E N ^a   Dokianakis, D N ^a   Spandidos, D A ^a  

^a UNIVERSITY OF CRETE   (Greece)

Author keywords

Breast cancer; H ras; Intron 1; VTR

Indexed keywords

DNA; H RAS PROTEIN; NUCLEOTIDE; PROTEIN P21; RAS PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ARTICLE; BLOOD SAMPLING; BREAST BIOPSY; BREAST CANCER; BREAST CARCINOGENESIS; CELL MEMBRANE; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA EXTRACTION; FEMALE; GENE ACTIVATION; GENE FREQUENCY; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE LOCUS; GENETIC ANALYSIS; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; INTRON; POLYMERASE CHAIN REACTION; POPULATION; RISK FACTOR; TUMOR; VARIABLE NUMBER OF TANDEM REPEAT;

EID: 0141920770     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.4305     Document Type: Article

References (13)

1. Dickson RB, Gottardis MM, Merlino GT. Molecular insights into breast cancer from transgenic mouse models. Bioassays 1991; 13: 591-6.
2. Kiaris H, Spandidos DA. Mutations of ras genes in human tumours (review). Int J Oncol 1995; 7: 413-21.
3. Spandidos, DA, ed. The Super-family of Ras Related Genes. New York, London: Plenum Press 1991.
4. Iwahana H, Orita M, Kanazawa H, Hayashi K, Sekiya TA. A new RFLP in intron 1 of the human c-Ha-ras1 gene and its close relationship with the variable tandem repeats in the region 3′ to the gene. Oncogene 1990; 5: 1049-53.
5. Tanci P, Genuardi M, Santini SA, Neri G. PCR detection of an insertion/deletion polymorphism in intron 1 of the HRAS1 locus. Nucleic Acids Res 1992; 20: 1157.
6. Kotsinas A, Vageli D, Varakliotou A, Anezinis P, Cranidis A, Spandidos DA. Genomic instability and LOH at two polymorphic sites at the H-ras1 gene. Int J Oncol 1994; 5: 1249-53.
7. Kiaris H, Spandidos DA, Jones AS, Field JK. Loss of heterozygosity and microsatellite instability of cancer of the head and neck. Int J Oncol 1994; 5: 579-82.
8. Diakoumis E, Sourvinos G, Kiaris H, Delakas D, Cranidis A, Spandidos DA. Genetic instability in renal cell carcinoma. Eur Urol 1998; 33: 227-32.
9. Sanchez-Cespedes M, Rosell R, Pifarre A, et al. Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer. Clin Cancer Res 1997; 3: 1229-35.
10. Roy N, Kahlem P, Dausse E, et al. Exclusion of HRAS from long QT locus. Nat Genet 1994; 8: 113-4.
11. Black DM. The genetics of breast cancer. Eur J Cancer 1994; 30A: 1957-61.
12. Langdon J, Armour J. Evolution and population genetics of the H-ras minisatellite and cancer predisposition. Hum Mol Genet 2003; 12: 891-900.
13. Weitzel J, Ding S, Larson G, et al. The HRAS1 minisatellite locus and risk of ovarian cancer. Cancer Res 2000; 60: 259-61.